Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 286,933 | -644,786 | -881,708 | -2,003,815 | -1,457,816 |
| Depreciation Amortization | 141,686 | 171,762 | 87,675 | 66,278 | 46,457 |
| Income taxes - deferred | 9,469 | 25,983 | 689 | 2,059 | 3,377 |
| Accounts receivable | -164,954 | -329,443 | -188,306 | 304,112 | -423,019 |
| Accounts payable and accrued liabilities | 79,833 | 121,497 | 21,484 | -4,352 | 20,008 |
| Other Working Capital | 190,898 | -157,167 | -370,539 | 132,391 | -118,345 |
| Other Operating Activity | 583,715 | 671,523 | 173,252 | 6,708 | 630,615 |
| Operating Cash Flow | $1,127,580 | $-140,631 | $-1,157,453 | $-1,496,619 | $-1,298,723 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,446 | 2,655 | 673,240 | 1,562,133 | 999,010 |
| PPE Investments | -185,839 | -492,663 | -561,896 | -325,434 | -262,942 |
| Purchase Of Investment | -11,834 | -19,006 | -14,900 | -15,911 | -43,500 |
| Purchase Sale Intangibles | -20,000 | -4,674 | -19,365 | N/A | -43,409 |
| Other Investing Activity | -81,928 | -39,336 | -36,440 | -143,665 | -51,909 |
| Investing Cash Flow | $-276,155 | $-548,350 | $60,004 | $1,077,123 | $640,659 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 233,676 | 868,270 | 661,530 | 313,774 | 406,449 |
| Debt Issued | 850,586 | 9,053 | 22,502 | 37,372 | 16,838 |
| Debt Repayment | -35,680 | -28,031 | -13,690 | N/A | N/A |
| Common Stock Issued | 196,281 | 45,373 | 55,712 | 46,964 | 3,535,378 |
| Other Financing Activity | -185,412 | -701,216 | -309,576 | -417,081 | -321,754 |
| Financing Cash Flow | $1,059,451 | $193,449 | $416,478 | $-18,971 | $3,636,911 |
| Exchange Rate Effect | 60,024 | -51,705 | -8,082 | -69,383 | 14,035 |
| Beginning Cash Position | 2,638,747 | 3,185,984 | 3,875,037 | 4,382,887 | 1,390,005 |
| End Cash Position | 4,609,647 | 2,638,747 | 3,185,984 | 3,875,037 | 4,382,887 |
| Net Cash Flow | $1,970,900 | $-547,237 | $-689,053 | $-507,850 | $2,992,882 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,127,580 | -140,631 | -1,157,453 | -1,496,619 | -1,298,723 |
| Capital Expenditure | -185,839 | -492,663 | -561,896 | -325,434 | -262,942 |
| Free Cash Flow | 941,741 | -633,294 | -1,719,349 | -1,822,053 | -1,561,665 |